Drug intelligence / Profile preview

clocortolone caproate

Development stage
Preclinical
Lead developer
Bayer HealthCare Pharmaceuticals
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Topical
01

Overview

Clocortolone caproate is a synthetic corticosteroid ester used primarily for its anti-inflammatory and antipruritic properties in dermatological conditions. It acts as a prodrug of clocortolone and exerts its effects by binding to the glucocorticoid receptor (NR3C1), leading to the induction of lipocortins that inhibit phospholipase A2. This inhibition reduces the release of arachidonic acid from membrane phospholipids and decreases synthesis of pro-inflammatory mediators such as prostaglandins and leukotrienes. The result is reduced inflammation and immune response in affected tissues. Clocortolone caproate is characterized by moderate potency as a topical corticosteroid with high lipid solubility for effective skin penetration[2][3][5]. Its primary indication is for corticosteroid-responsive dermatoses.

Other names
clocortolone hexanoateCLOCORTOLONE HEXANOATE [WHO-DD]9-chloro-6alpha-fluoro-11beta,21-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 21-hexanoate
02

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on clocortolone caproate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on clocortolone caproate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call